The determination of the difference in event rates between a control group and a treatment group is a fundamental statistical process. This process quantifies the decrease in risk attributable to a specific intervention. For example, if a placebo group experiences a 10% occurrence of a certain outcome, while a treatment group experiences only a 6% occurrence, this difference is calculated.
This specific calculation is crucial for interpreting the practical impact of interventions. It allows stakeholders to assess the real-world benefits of a treatment, supplementing information derived from relative risk measures. Its use has evolved alongside advances in evidence-based medicine, becoming a standard metric for evaluating healthcare interventions and informing clinical decision-making.